A Phase 2b, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy and Safety of BIIB122 in Participants with Parkinson's Disease
![](https://researchstudies.cuanschutz.edu/Content/images/study-category-images/brain-nervous.jpg)
Details
Age
Adult
Locations
Outpatient CTRC
University of Colorado Hospital
Principal Investigator
![Photograph of Emily Forbes](https://som.ucdenver.edu/FIMS/Content/faculty/31757/CU-Doctors-31757.jpg)
Emily Forbes
Study ID
Protocol Number: 22-0285
More information available at ClinicalTrials.gov: NCT05348785
Categories
Is this Study for You?
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers